Enzon Pharmaceuticals Inc (ENZN)
0.1402
-0.01
(-6.53%)
USD |
OTCM |
Jun 14, 16:00
Enzon Pharmaceuticals Total Liabilities (Quarterly): 43.54M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 43.54M |
| December 31, 2023 | 44.20M |
| September 30, 2023 | 44.48M |
| June 30, 2023 | 43.95M |
| March 31, 2023 | 43.42M |
| December 31, 2022 | 44.18M |
| September 30, 2022 | 44.50M |
| June 30, 2022 | 43.92M |
| March 31, 2022 | 43.42M |
| December 31, 2021 | 42.89M |
| September 30, 2021 | 42.36M |
| June 30, 2021 | 41.91M |
| March 31, 2021 | 41.43M |
| December 31, 2020 | 40.87M |
| September 30, 2020 | 0.654M |
| June 30, 2020 | 0.427M |
| March 31, 2020 | 0.424M |
| December 31, 2019 | 0.423M |
| September 30, 2019 | 5.753M |
| June 30, 2019 | 0.455M |
| March 31, 2019 | 0.585M |
| December 31, 2018 | 0.517M |
| September 30, 2018 | 0.623M |
| June 30, 2018 | 0.379M |
| March 31, 2018 | 0.468M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.368M |
| September 30, 2017 | 0.371M |
| June 30, 2017 | 0.487M |
| March 31, 2017 | 0.322M |
| December 31, 2016 | 0.94M |
| September 30, 2016 | 0.163M |
| June 30, 2016 | 0.15M |
| March 31, 2016 | 0.256M |
| December 31, 2015 | 4.801M |
| September 30, 2015 | 4.761M |
| June 30, 2015 | 22.83M |
| March 31, 2015 | 1.06M |
| December 31, 2014 | 5.437M |
| September 30, 2014 | 1.102M |
| June 30, 2014 | 1.263M |
| March 31, 2014 | 1.444M |
| December 31, 2013 | 1.866M |
| September 30, 2013 | 3.083M |
| June 30, 2013 | 2.60M |
| March 31, 2013 | 122.84M |
| December 31, 2012 | 122.31M |
| September 30, 2012 | 124.75M |
| June 30, 2012 | 125.53M |
| March 31, 2012 | 139.80M |
| December 31, 2011 | 146.03M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.423M
Minimum
Dec 2019
44.50M
Maximum
Sep 2022
30.66M
Average
42.62M
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 11.36M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Electromed Inc | 6.357M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.83M |
| Shareholders Equity (Quarterly) | 3.294M |